Damora Therapeutics, Inc. · NASDAQ:DMRA
Avoro Capital Advisors LLC reported a 6.27% stake in Damora Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed May 15, 2026
Avoro Capital Advisors LLC reported a 6.27% stake in Damora Therapeutics, Inc., 3,783,000 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).
- Stake
- 6.27%
- Shares
- 3,783,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Avoro Capital Advisors LLC | 6.27% | 3,783,000 |
| Behzad Aghazadeh | 6.27% | 3,783,000 |
Source
Related
- Damora Therapeutics, Inc.
- Avoro Capital Advisors LLC
- Damora Therapeutics, Inc. shareholders
- Form 4 · Jarrett Jennifer · Sep 28, 2026
- Schedule 13G · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Winslow Garrett · Jul 7, 2026
- Schedule 13G/A · Jain Global LLC · May 15, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · May 15, 2026